tirzepatide companies FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Lilly seeks to intervene in

Tracking protein intake for the first few weeks helps establish good habits

Ruthia He, founder and CEO of Done Global, and David Brody, the clinical president of Done Health, were each convicted on one count of conspiracy to distribute controlled substances, four counts of distribution of controlled substances, and one count of conspiracy to commit health care fraud, according to a press release from DOJ

When considering semaglutide or bupropion for weight loss, it is crucial to understand the potential precautions and interactions associated with each medication

Several pharmacological options can help manage GLP-1-induced nausea when lifestyle modifications prove insufficient